As of 2025-01-15, the Relative Valuation of Medifast Inc (MED) is 58.30 USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.25 USD, the upside of Medifast Inc based on Relative Valuation is 282.3%.
The range of the Relative Valuation is 15.27 - 128.89 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.8x - 26.9x | 22.8x |
| Forward P/E multiples | 16.7x - 25.4x | 20.0x |
| Fair Price | 15.27 - 128.89 | 58.30 |
| Upside | 0.1% - 745.2% | 282.3% |
| Date | P/E |
| 2025-01-10 | 23.59 |
| 2025-01-08 | 23.36 |
| 2025-01-07 | 24.52 |
| 2025-01-06 | 24.76 |
| 2025-01-03 | 26.28 |
| 2025-01-02 | 25.82 |
| 2024-12-31 | 26.31 |
| 2024-12-30 | 26.57 |
| 2024-12-27 | 26.28 |
| 2024-12-26 | 26.52 |
| 2024-12-24 | 25.34 |
| 2024-12-23 | 25.16 |
| 2024-12-20 | 25.27 |
| 2024-12-19 | 25.60 |
| 2024-12-18 | 26.54 |
| 2024-12-17 | 27.76 |
| 2024-12-16 | 27.22 |
| 2024-12-13 | 28.61 |
| 2024-12-12 | 30.09 |
| 2024-12-11 | 31.33 |
| 2024-12-10 | 32.49 |
| 2024-12-09 | 31.34 |
| 2024-12-06 | 29.96 |
| 2024-12-05 | 29.81 |
| 2024-12-04 | 29.48 |
| 2024-12-03 | 28.70 |
| 2024-12-02 | 29.63 |
| 2024-11-29 | 29.37 |
| 2024-11-27 | 29.03 |
| 2024-11-26 | 27.36 |
| 2024-11-25 | 27.81 |
| 2024-11-22 | 27.49 |
| 2024-11-21 | 27.33 |
| 2024-11-20 | 27.12 |
| 2024-11-19 | 25.86 |
| 2024-11-18 | 26.24 |
| 2024-11-15 | 27.09 |
| 2024-11-14 | 27.30 |
| 2024-11-13 | 29.22 |
| 2024-11-12 | 28.99 |
| 2024-11-11 | 29.02 |
| 2024-11-08 | 28.61 |
| 2024-11-07 | 29.69 |
| 2024-11-06 | 29.42 |
| 2024-11-05 | 30.46 |
| 2024-11-04 | 28.09 |
| 2024-11-01 | 27.75 |
| 2024-10-31 | 27.45 |
| 2024-10-30 | 27.91 |
| 2024-10-29 | 27.64 |